Anticancer Res. 1997 May-Jun;17(3B):1607-10. Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer. Schillaci O, Scopinaro F, Danieli R, Tavolaro R, Cannas P, Picardi V, Colella AC. SourceDepartment of Experimental Medicine and Pathology, University La Sapienza, Rome, Italy. Abstract BACKGROUND: The status of the axillary lymph nodes is the most important prognostic factor in breast cancer, and the findings of axillary node dissection remain the gold standard for the patients staging and prognosis. The aim of this study was to evaluate the usefulness of Tc-99m sestamibi scintigraphy in the detection of axillary node involvement. MATERIALS AND METHODS: Forty-nine patients (age range: 32-72 years) with breast cancer were studied. Dynamic images (1-20 minutes post-injection of the radiopharmaceutical) followed by multiple planar views and tomographic images were performed. Final diagnosis was achieved by histology after surgery. RESULTS: Metastatic axillary lymph node involvement was present in 21 patients: sensitivity was 81% (17/21) for tomographic and 61.9% (13/21) for planar images; specificity was 92.9% (26/28) and 96.4% (27/28), respectively. CONCLUSIONS: Tc-99m sestamibi imaging is a promising noninvasive method to detect axillary node metastases in patients with breast cancer, tomography appears more sensitive than planar views. PMID:9179202[PubMed - indexed for MEDLINE]

Technetium-99m Sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer / Schillaci, O.; Scopinaro, Francesco; Danieli, R.; Tavolaro, R.; Cannas, P.; Picardi, V.; CENTI COLELLA, A.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 17:(1997), pp. 1607-1610.

Technetium-99m Sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer.

SCOPINARO, Francesco;
1997

Abstract

Anticancer Res. 1997 May-Jun;17(3B):1607-10. Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer. Schillaci O, Scopinaro F, Danieli R, Tavolaro R, Cannas P, Picardi V, Colella AC. SourceDepartment of Experimental Medicine and Pathology, University La Sapienza, Rome, Italy. Abstract BACKGROUND: The status of the axillary lymph nodes is the most important prognostic factor in breast cancer, and the findings of axillary node dissection remain the gold standard for the patients staging and prognosis. The aim of this study was to evaluate the usefulness of Tc-99m sestamibi scintigraphy in the detection of axillary node involvement. MATERIALS AND METHODS: Forty-nine patients (age range: 32-72 years) with breast cancer were studied. Dynamic images (1-20 minutes post-injection of the radiopharmaceutical) followed by multiple planar views and tomographic images were performed. Final diagnosis was achieved by histology after surgery. RESULTS: Metastatic axillary lymph node involvement was present in 21 patients: sensitivity was 81% (17/21) for tomographic and 61.9% (13/21) for planar images; specificity was 92.9% (26/28) and 96.4% (27/28), respectively. CONCLUSIONS: Tc-99m sestamibi imaging is a promising noninvasive method to detect axillary node metastases in patients with breast cancer, tomography appears more sensitive than planar views. PMID:9179202[PubMed - indexed for MEDLINE]
1997
01 Pubblicazione su rivista::01a Articolo in rivista
Technetium-99m Sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer / Schillaci, O.; Scopinaro, Francesco; Danieli, R.; Tavolaro, R.; Cannas, P.; Picardi, V.; CENTI COLELLA, A.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 17:(1997), pp. 1607-1610.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/87532
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 29
  • ???jsp.display-item.citation.isi??? ND
social impact